 | | 75G | | Name: | (2S,4aR,6R,7R,7aS)-6-(6-amino-2-chloro-9H-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-2-one | | Formula: | C10 H11 Cl N5 O5 P S | | SMILES: | c4(nc3n(C2OC1COP(S)(=O)OC1C2O)cnc3c(N)n4)Cl | | InChi: | InChI=1S/C10H11ClN5O5PS/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-5(17)6-3(20-9)1-19-22(18,23)21-6/h2-3,5-6,9,17H,1H2,(H,18,23)(H2,12,14,15)/t3-,5-,6-,9-,22+/m1/s1 | | Synonyms: | Sp-2-Cl-cAMPS | | Definition date: | 2016-08-29 | | Last modified: | 2020-02-12 | | Release date: | 2016-10-12 | | Identifier: | (2S,4aR,6R,7R,7aS)-6-(6-amino-2-chloro-9H-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-2-one |
|
 | | 1FJ | | Name: | ~{N}-(2,3-dimethylphenyl)-7-oxidanylidene-12-sulfanylidene-5,11-dithia-1,8-diazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),3,9-triene-10-carboxamide | | Formula: | C17 H13 N3 O2 S3 | | SMILES: | Cc1cccc(NC(=O)C2=C3NC(=O)c4sccc4N3C(=S)S2)c1C | | InChi: | InChI=1S/C17H13N3O2S3/c1-8-4-3-5-10(9(8)2)18-16(22)13-14-19-15(21)12-11(6-7-24-12)20(14)17(23)25-13/h3-7H,1-2H3,(H,18,22)(H,19,21) | | Definition date: | 2013-01-16 | | Last modified: | 2020-02-12 | | Release date: | 2013-09-11 | | Identifier: | ~{N}-(2,3-dimethylphenyl)-7-oxidanylidene-12-sulfanylidene-5,11-dithia-1,8-diazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),3,9-triene-10-carboxamide |
|
 | | 0F2 | | Name: | 3-[4-(2-morpholin-4-ylethoxy)-2-(1~{H}-thieno[3,2-c]pyrazol-3-yl)-1~{H}-indol-6-yl]pentan-3-ol | | Formula: | C24 H30 N4 O3 S | | SMILES: | CCC(O)(CC)c1cc2[nH]c(cc2c(OCCN3CCOCC3)c1)c4n[nH]c5ccsc45 | | InChi: | InChI=1S/C24H30N4O3S/c1-3-24(29,4-2)16-13-19-17(21(14-16)31-11-8-28-6-9-30-10-7-28)15-20(25-19)22-23-18(26-27-22)5-12-32-23/h5,12-15,25,29H,3-4,6-11H2,1-2H3,(H,26,27) | | Definition date: | 2011-12-30 | | Last modified: | 2020-02-12 | | Identifier: | 3-[4-(2-morpholin-4-ylethoxy)-2-(1~{H}-thieno[3,2-c]pyrazol-3-yl)-1~{H}-indol-6-yl]pentan-3-ol |
|
 | | 0F5 | | Name: | (5~{Z})-5-[[3-[6-[(4-azanylcyclohexyl)amino]pyrazin-2-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione | | Formula: | C20 H21 N5 O2 S | | SMILES: | N[CH]1CC[CH](CC1)Nc2cncc(n2)c3cccc(C=C4SC(=O)NC4=O)c3 | | InChi: | InChI=1S/C20H21N5O2S/c21-14-4-6-15(7-5-14)23-18-11-22-10-16(24-18)13-3-1-2-12(8-13)9-17-19(26)25-20(27)28-17/h1-3,8-11,14-15H,4-7,21H2,(H,23,24)(H,25,26,27)/b17-9-/t14-,15- | | Definition date: | 2012-01-04 | | Last modified: | 2020-02-12 | | Identifier: | (5~{Z})-5-[[3-[6-[(4-azanylcyclohexyl)amino]pyrazin-2-yl]phenyl]methylidene]-1,3-thiazolidine-2,4-dione |
|
 | | 2RY | | Name: | 1-[4-(7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(12),2(6),8,10-tetraen-12-yl)piperazin-1-yl]-2-[2-(trifluoromethyl)phenyl]ethanone | | Formula: | C22 H21 F3 N4 O S | | SMILES: | FC(F)(F)c1ccccc1CC(=O)N2CCN(CC2)c3ncnc4sc5CCCc5c34 | | InChi: | InChI=1S/C22H21F3N4OS/c23-22(24,25)16-6-2-1-4-14(16)12-18(30)28-8-10-29(11-9-28)20-19-15-5-3-7-17(15)31-21(19)27-13-26-20/h1-2,4,6,13H,3,5,7-12H2 | | Definition date: | 2014-01-15 | | Last modified: | 2020-02-12 | | Release date: | 2014-07-02 | | Identifier: | 1-[4-(7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(12),2(6),8,10-tetraen-12-yl)piperazin-1-yl]-2-[2-(trifluoromethyl)phenyl]ethanone |
|
 | | 2PK | | Name: | (5~{E})-2-azanylidene-5-[(4-hydroxyphenyl)methylidene]-1,3-thiazolidin-4-one | | Formula: | C10 H8 N2 O2 S | | SMILES: | Oc1ccc(cc1)C=C2SC(=N)NC2=O | | InChi: | InChI=1S/C10H8N2O2S/c11-10-12-9(14)8(15-10)5-6-1-3-7(13)4-2-6/h1-5,13H,(H2,11,12,14)/b8-5+ | | Definition date: | 2013-12-24 | | Last modified: | 2020-02-12 | | Release date: | 2014-01-08 | | Identifier: | (5~{E})-2-azanylidene-5-[(4-hydroxyphenyl)methylidene]-1,3-thiazolidin-4-one |
|
 | | 2PV | | Name: | (5~{E})-5-[(4-aminophenyl)methylidene]-2-azanylidene-1,3-thiazolidin-4-one | | Formula: | C10 H9 N3 O S | | SMILES: | Nc1ccc(cc1)C=C2SC(=N)NC2=O | | InChi: | InChI=1S/C10H9N3OS/c11-7-3-1-6(2-4-7)5-8-9(14)13-10(12)15-8/h1-5H,11H2,(H2,12,13,14)/b8-5+ | | Definition date: | 2013-12-24 | | Last modified: | 2020-02-12 | | Release date: | 2014-01-08 | | Identifier: | (5~{E})-5-[(4-aminophenyl)methylidene]-2-azanylidene-1,3-thiazolidin-4-one |
|
 | | 2PW | | Name: | (5~{E})-3-[(2~{R})-butan-2-yl]-5-[(4-hydroxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | | Formula: | C14 H15 N O2 S2 | | SMILES: | CC[CH](C)N1C(=S)SC(=Cc2ccc(O)cc2)C1=O | | InChi: | InChI=1S/C14H15NO2S2/c1-3-9(2)15-13(17)12(19-14(15)18)8-10-4-6-11(16)7-5-10/h4-9,16H,3H2,1-2H3/b12-8+/t9-/m1/s1 | | Definition date: | 2013-12-24 | | Last modified: | 2020-02-12 | | Release date: | 2014-01-08 | | Identifier: | (5~{E})-3-[(2~{R})-butan-2-yl]-5-[(4-hydroxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
|
 | | 2Q0 | | Name: | (5~{Z})-5-[(4-hydroxyphenyl)methylidene]-3-(2-methylpropyl)-2-sulfanylidene-1,3-thiazolidin-4-one | | Formula: | C14 H15 N O2 S2 | | SMILES: | CC(C)CN1C(=S)SC(=Cc2ccc(O)cc2)C1=O | | InChi: | InChI=1S/C14H15NO2S2/c1-9(2)8-15-13(17)12(19-14(15)18)7-10-3-5-11(16)6-4-10/h3-7,9,16H,8H2,1-2H3/b12-7- | | Definition date: | 2013-12-29 | | Last modified: | 2020-02-12 | | Release date: | 2014-01-15 | | Identifier: | (5~{Z})-5-[(4-hydroxyphenyl)methylidene]-3-(2-methylpropyl)-2-sulfanylidene-1,3-thiazolidin-4-one |
|
 | | QXY | | Name: | {4-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]phenyl}(4-ethylpiperazin-1-yl)methanone | | Formula: | C19 H26 N4 O | | SMILES: | C1CN(CCN1C(c2ccc(cc2)Cn3c(cc(n3)C)C)=O)CC | | InChi: | InChI=1S/C19H26N4O/c1-4-21-9-11-22(12-10-21)19(24)18-7-5-17(6-8-18)14-23-16(3)13-15(2)20-23/h5-8,13H,4,9-12,14H2,1-3H3 | | Definition date: | 2020-01-14 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | {4-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]phenyl}(4-ethylpiperazin-1-yl)methanone |
|
 | | PQV | | Name: | (2E)-N-[2-(azepan-1-yl)ethyl]-2-(hydroxyimino)acetamide | | Formula: | C10 H19 N3 O2 | | SMILES: | C1N(CCCCC1)CCNC(C=NO)=O | | InChi: | InChI=1S/C10H19N3O2/c14-10(9-12-15)11-5-8-13-6-3-1-2-4-7-13/h9,15H,1-8H2,(H,11,14)/b12-9+ | | Definition date: | 2019-08-23 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | (2E)-N-[2-(azepan-1-yl)ethyl]-2-(hydroxyimino)acetamide |
|
 | | QKG | | Name: | 4-(7-methoxy-1-methyl-9H-beta-carbolin-9-yl)butanamide | | Formula: | C17 H19 N3 O2 | | SMILES: | C(Cn3c1c(ccc(c1)OC)c2ccnc(C)c23)CC(=O)N | | InChi: | InChI=1S/C17H19N3O2/c1-11-17-14(7-8-19-11)13-6-5-12(22-2)10-15(13)20(17)9-3-4-16(18)21/h5-8,10H,3-4,9H2,1-2H3,(H2,18,21) | | Definition date: | 2019-11-06 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | 4-(7-methoxy-1-methyl-9H-beta-carbolin-9-yl)butanamide |
|
 | | PQY | | Name: | (2E,2'E)-N,N'-[1,4-diazepane-1,4-diyldi(ethane-2,1-diyl)]bis[2-(hydroxyimino)acetamide] | | Formula: | C13 H24 N6 O4 | | SMILES: | N1(CCNC(C=NO)=O)CCN(CCNC([C@H]=NO)=O)CCC1 | | InChi: | InChI=1S/C13H24N6O4/c20-12(10-16-22)14-2-6-18-4-1-5-19(9-8-18)7-3-15-13(21)11-17-23/h10-11,22-23H,1-9H2,(H,14,20)(H,15,21)/b16-10+,17-11+ | | Definition date: | 2019-08-23 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | (2E,2'E)-N,N'-[1,4-diazepane-1,4-diyldi(ethane-2,1-diyl)]bis[2-(hydroxyimino)acetamide] |
|
 | | S6M | | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-4-[1-(2,2,6,6-tetramethyl-1-oxidanyl-piperidin-4-yl)-1,2,3-triazol-4-yl]oxolan-2-yl]methyl dihydrogen phosphate | | Formula: | C20 H31 N6 O9 P | | SMILES: | CC1(C)CC(CC(C)(C)N1O)n2cc(nn2)[CH]3[CH](O)[CH](CO[P](O)(O)=O)O[CH]3N4C=CC(=O)NC4=O | | InChi: | InChI=1S/C20H31N6O9P/c1-19(2)7-11(8-20(3,4)26(19)30)25-9-12(22-23-25)15-16(28)13(10-34-36(31,32)33)35-17(15)24-6-5-14(27)21-18(24)29/h5-6,9,11,13,15-17,28,30H,7-8,10H2,1-4H3,(H,21,27,29)(H2,31,32,33)/t13-,15-,16-,17-/m1/s1 | | Definition date: | 2019-01-25 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-4-[1-(2,2,6,6-tetramethyl-1-oxidanyl-piperidin-4-yl)-1,2,3-triazol-4-yl]oxolan-2-yl]methyl dihydrogen phosphate |
|
 | | R54 | | Name: | (5R,6S)-5-(4-{2-[(2S)-2-methylpyrrolidin-1-yl]ethoxy}phenyl)-6-phenyl-5,6,7,8-tetrahydronaphthalen-2-ol | | Formula: | C29 H33 N O2 | | SMILES: | CC1CCCN1CCOc2ccc(cc2)C4c3ccc(O)cc3CCC4c5ccccc5 | | InChi: | InChI=1S/C29H33NO2/c1-21-6-5-17-30(21)18-19-32-26-13-9-23(10-14-26)29-27(22-7-3-2-4-8-22)15-11-24-20-25(31)12-16-28(24)29/h2-4,7-10,12-14,16,20-21,27,29,31H,5-6,11,15,17-19H2,1H3/t21-,27+,29-/m0/s1 | | Definition date: | 2020-01-30 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | (5R,6S)-5-(4-{2-[(2S)-2-methylpyrrolidin-1-yl]ethoxy}phenyl)-6-phenyl-5,6,7,8-tetrahydronaphthalen-2-ol |
|
 | | WI5 | | Name: | {(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone | | Formula: | C27 H26 N2 O3 | | SMILES: | c2ccc1cccc(c1c2)C(=O)c3c(C)n5C(COc4cccc3c45)CN6CCOCC6 | | InChi: | InChI=1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3/t20-/m1/s1 | | Definition date: | 2019-07-15 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | {(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone |
|
 | | A0O | | Name: | 7-methoxy-8-(3-methylbut-2-enyl)chromen-2-one | | Formula: | C15 H16 O3 | | SMILES: | COc1ccc2C=CC(=O)Oc2c1CC=C(C)C | | InChi: | InChI=1S/C15H16O3/c1-10(2)4-7-12-13(17-3)8-5-11-6-9-14(16)18-15(11)12/h4-6,8-9H,7H2,1-3H3 | | Definition date: | 2018-09-12 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | 7-methoxy-8-(3-methylbut-2-enyl)chromen-2-one |
|
 | | 84S | | Name: | N-(6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}imidazo[1,2-b]pyridazin-2-yl)cyclopropanecarboxamide | | Formula: | C21 H17 F2 N9 O | | SMILES: | c1(cnn(C)c1)c6cn5c(nnc5C(c4ccc2n(cc(n2)NC(=O)C3CC3)n4)(F)F)cc6 | | InChi: | InChI=1S/C21H17F2N9O/c1-30-9-14(8-24-30)13-4-6-18-27-28-20(31(18)10-13)21(22,23)15-5-7-17-25-16(11-32(17)29-15)26-19(33)12-2-3-12/h4-12H,2-3H2,1H3,(H,26,33) | | Definition date: | 2016-12-24 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | N-(6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}imidazo[1,2-b]pyridazin-2-yl)cyclopropanecarboxamide |
|
 | | J4B | | Name: | ~{N}'-[(2~{S})-2-[3,5-bis(fluoranyl)phenyl]-2-oxidanyl-ethanoyl]-2-ethyl-3-methyl-4-oxidanyl-benzohydrazide | | Formula: | C18 H18 F2 N2 O4 | | SMILES: | CCc1c(C)c(O)ccc1C(=O)NNC(=O)[CH](O)c2cc(F)cc(F)c2 | | InChi: | InChI=1S/C18H18F2N2O4/c1-3-13-9(2)15(23)5-4-14(13)17(25)21-22-18(26)16(24)10-6-11(19)8-12(20)7-10/h4-8,16,23-24H,3H2,1-2H3,(H,21,25)(H,22,26)/t16-/m0/s1 | | Definition date: | 2019-01-23 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | ~{N}'-[(2~{S})-2-[3,5-bis(fluoranyl)phenyl]-2-oxidanyl-ethanoyl]-2-ethyl-3-methyl-4-oxidanyl-benzohydrazide |
|
 | | J4T | | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-4-[1-[(2,2,5,5-tetramethyl-1-oxidanyl-pyrrol-3-yl)methyl]-1,2,3-triazol-4-yl]oxolan-2-yl]methyl dihydrogen phosphate | | Formula: | C20 H29 N6 O9 P | | SMILES: | CC1(C)C=C(Cn2cc(nn2)[CH]3[CH](O)[CH](CO[P](O)(O)=O)O[CH]3N4C=CC(=O)NC4=O)C(C)(C)N1O | | InChi: | InChI=1S/C20H29N6O9P/c1-19(2)7-11(20(3,4)26(19)30)8-24-9-12(22-23-24)15-16(28)13(10-34-36(31,32)33)35-17(15)25-6-5-14(27)21-18(25)29/h5-7,9,13,15-17,28,30H,8,10H2,1-4H3,(H,21,27,29)(H2,31,32,33)/t13-,15-,16-,17-/m1/s1 | | Definition date: | 2019-01-25 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-4-[1-[(2,2,5,5-tetramethyl-1-oxidanyl-pyrrol-3-yl)methyl]-1,2,3-triazol-4-yl]oxolan-2-yl]methyl dihydrogen phosphate |
|
 | | J58 | | Name: | 3-bromanyl-2~{H}-indazol-5-amine | | Formula: | C7 H6 Br N3 | | SMILES: | Nc1ccc2n[nH]c(Br)c2c1 | | InChi: | InChI=1S/C7H6BrN3/c8-7-5-3-4(9)1-2-6(5)10-11-7/h1-3H,9H2,(H,10,11) | | Definition date: | 2019-01-25 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | 3-bromanyl-2~{H}-indazol-5-amine |
|
 | | CKL | | Name: | 4-[(2-azanyl-4-oxidanylidene-7,8-dihydro-3~{H}-pteridin-6-yl)methylamino]-~{N}-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide | | Formula: | C19 H21 N9 O5 S | | SMILES: | COc1ncnc(N[S](=O)(=O)c2ccc(NCC3=NC4=C(NC3)N=C(N)NC4=O)cc2)c1OC | | InChi: | InChI=1S/C19H21N9O5S/c1-32-14-16(23-9-24-18(14)33-2)28-34(30,31)12-5-3-10(4-6-12)21-7-11-8-22-15-13(25-11)17(29)27-19(20)26-15/h3-6,9,21H,7-8H2,1-2H3,(H,23,24,28)(H4,20,22,26,27,29) | | Definition date: | 2019-04-25 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | 4-[(2-azanyl-4-oxidanylidene-7,8-dihydro-3~{H}-pteridin-6-yl)methylamino]-~{N}-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide |
|
 | | BV9 | | Name: | 4-[5-(1-methylpyrazol-4-yl)pyridin-3-yl]benzamide | | Formula: | C16 H14 N4 O | | SMILES: | Cn1cc(cn1)c2cncc(c2)c3ccc(cc3)C(N)=O | | InChi: | InChI=1S/C16H14N4O/c1-20-10-15(9-19-20)14-6-13(7-18-8-14)11-2-4-12(5-3-11)16(17)21/h2-10H,1H3,(H2,17,21) | | Definition date: | 2019-03-13 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | 4-[5-(1-methylpyrazol-4-yl)pyridin-3-yl]benzamide |
|
 | | L4M | | Name: | 4-{[(1S,2S)-2-(carboxymethyl)cyclopentyl]methyl}benzoic acid | | Formula: | C15 H18 O4 | | SMILES: | C1(CCCC1CC(O)=O)Cc2ccc(cc2)C(O)=O | | InChi: | InChI=1S/C15H18O4/c16-14(17)9-13-3-1-2-12(13)8-10-4-6-11(7-5-10)15(18)19/h4-7,12-13H,1-3,8-9H2,(H,16,17)(H,18,19)/t12-,13-/m0/s1 | | Definition date: | 2019-02-06 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | 4-{[(1S,2S)-2-(carboxymethyl)cyclopentyl]methyl}benzoic acid |
|
 | | L4S | | Name: | 2',5'-dideoxy-5'-[4-({[(1S,2R)-2-(2-hydroxybenzene-1-carbonyl)cyclopentyl]acetyl}amino)-1H-1,2,3-triazol-1-yl]cytidine | | Formula: | C25 H29 N7 O6 | | SMILES: | C(=O)(Nc3nnn(CC2C(CC(N1C=CC(N)=NC1=O)O2)O)c3)CC5CCCC5C(c4ccccc4O)=O | | InChi: | InChI=1S/C25H29N7O6/c26-20-8-9-32(25(37)27-20)23-11-18(34)19(38-23)12-31-13-21(29-30-31)28-22(35)10-14-4-3-6-15(14)24(36)16-5-1-2-7-17(16)33/h1-2,5,7-9,13-15,18-19,23,33-34H,3-4,6,10-12H2,(H,28,35)(H2,26,27,37)/t14-,15+,18-,19+,23+/m0/s1 | | Definition date: | 2019-02-06 | | Last modified: | 2020-02-07 | | Release date: | 2020-02-12 | | Identifier: | 2',5'-dideoxy-5'-[4-({[(1S,2R)-2-(2-hydroxybenzene-1-carbonyl)cyclopentyl]acetyl}amino)-1H-1,2,3-triazol-1-yl]cytidine |
|